RhumbLine Advisers’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39
| Closed | -$273 | – | 4327 |
|
|
2024
Q2 | $273 | Sell |
39
-3
| -7% | -$21 | ﹤0.01% | 4314 |
|
|
2024
Q1 | $766 | Hold |
42
| – | – | ﹤0.01% | 4167 |
|
|
2023
Q4 | $451 | Hold |
42
| – | – | ﹤0.01% | 4203 |
|
|
2023
Q3 | $840 | Hold |
42
| – | – | ﹤0.01% | 4198 |
|
|
2023
Q2 | $3.25K | Buy |
+42
| New | +$3.25K | ﹤0.01% | 4151 |
|
|
2022
Q2 | – | Sell |
-1,460
| Closed | -$143K | – | 3232 |
|
|
2022
Q1 | $143K | Sell |
1,460
-10
| -0.7% | -$979 | ﹤0.01% | 2829 |
|
|
2021
Q4 | $240K | Sell |
1,470
-29
| -2% | -$4.74K | ﹤0.01% | 2783 |
|
|
2021
Q3 | $409K | Buy |
1,499
+42
| +3% | +$11.5K | ﹤0.01% | 2632 |
|
|
2021
Q2 | $577K | Sell |
1,457
-366
| -20% | -$145K | ﹤0.01% | 2502 |
|
|
2021
Q1 | $984K | Sell |
1,823
-146
| -7% | -$78.8K | ﹤0.01% | 2197 |
|
|
2020
Q4 | $744K | Buy |
1,969
+195
| +11% | +$73.7K | ﹤0.01% | 2268 |
|
|
2020
Q3 | $671K | Sell |
1,774
-286
| -14% | -$108K | ﹤0.01% | 2159 |
|
|
2020
Q2 | $1.01M | Buy |
2,060
+706
| +52% | +$348K | ﹤0.01% | 2039 |
|
|
2020
Q1 | $497K | Sell |
1,354
-17
| -1% | -$6.24K | ﹤0.01% | 2164 |
|
|
2019
Q4 | $971K | Buy |
1,371
+22
| +2% | +$15.6K | ﹤0.01% | 2099 |
|
|
2019
Q3 | $866K | Sell |
1,349
-9
| -0.7% | -$5.78K | ﹤0.01% | 2110 |
|
|
2019
Q2 | $1.19M | Buy |
1,358
+205
| +18% | +$179K | ﹤0.01% | 1986 |
|
|
2019
Q1 | $666K | Sell |
1,153
-14
| -1% | -$8.09K | ﹤0.01% | 2197 |
|
|
2018
Q4 | $327K | Buy |
1,167
+370
| +46% | +$104K | ﹤0.01% | 2499 |
|
|
2018
Q3 | $382K | Sell |
797
-62
| -7% | -$29.7K | ﹤0.01% | 2388 |
|
|
2018
Q2 | $389K | Buy |
859
+24
| +3% | +$10.9K | ﹤0.01% | 2420 |
|
|
2018
Q1 | $491K | Sell |
835
-29
| -3% | -$17.1K | ﹤0.01% | 2216 |
|
|
2017
Q4 | $536K | Sell |
864
-156
| -15% | -$96.8K | ﹤0.01% | 2204 |
|
|
2017
Q3 | $939K | Buy |
1,020
+13
| +1% | +$12K | ﹤0.01% | 2008 |
|
|
2017
Q2 | $940K | Buy |
1,007
+53
| +6% | +$49.5K | ﹤0.01% | 1979 |
|
|
2017
Q1 | $907K | Buy |
954
+33
| +4% | +$31.4K | ﹤0.01% | 1982 |
|
|
2016
Q4 | $739K | Buy |
921
+9
| +1% | +$7.22K | ﹤0.01% | 2013 |
|
|
2016
Q3 | $771K | Buy |
912
+2
| +0.2% | +$1.69K | ﹤0.01% | 1961 |
|
|
2016
Q2 | $749K | Buy |
910
+114
| +14% | +$93.8K | ﹤0.01% | 1963 |
|
|
2016
Q1 | $886K | Buy |
796
+1
| +0.1% | +$1.11K | ﹤0.01% | 1878 |
|
|
2015
Q4 | $991K | Buy |
795
+100
| +14% | +$125K | ﹤0.01% | 1803 |
|
|
2015
Q3 | $940K | Buy |
695
+8
| +1% | +$10.8K | ﹤0.01% | 1801 |
|
|
2015
Q2 | $1.24M | Buy |
687
+131
| +24% | +$236K | ﹤0.01% | 1728 |
|
|
2015
Q1 | $898K | Buy |
556
+111
| +25% | +$179K | ﹤0.01% | 1924 |
|
|
2014
Q4 | $338K | Buy |
445
+14
| +3% | +$10.6K | ﹤0.01% | 2511 |
|
|
2014
Q3 | $171K | Hold |
431
| – | – | ﹤0.01% | 2810 |
|
|
2014
Q2 | $261K | Buy |
431
+27
| +7% | +$16.4K | ﹤0.01% | 2678 |
|
|
2014
Q1 | $278K | Sell |
404
-16
| -4% | -$11K | ﹤0.01% | 2579 |
|
|
2013
Q4 | $273K | Buy |
420
+1
| +0.2% | +$650 | ﹤0.01% | 2644 |
|
|
2013
Q3 | $248K | Buy |
419
+2
| +0.5% | +$1.18K | ﹤0.01% | 2663 |
|
|
2013
Q2 | $131K | Buy |
+417
| New | +$131K | ﹤0.01% | 3174 |
|